Merck KGaA MRK

The global biomarkers market is projected to grow from USD 67.95 billion in 2026 to USD 112.10 billion by 2031, registering a 10.5% CAGR. Growth is driven by precision medicine, companion diagnostics, AI, bioinformatics, digital pathology and multi-omics technologies. Predictive biomarkers led the efficacy segment in 2025, while immunoassays held the largest technology share. Asia Pacific is forecast to be the fastest-growing region. Key players include Roche, Abbott, Thermo Fisher Scientific, Q

Demand for biologics, targeted therapies and personalized medicine is rising, while AI-led protein design and scalable bioprocessing unlock new opportunities.Dublin, Sept. 30, 2026 (GLOBE NEWSWIRE) -- "Recombinant Proteins Market - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global recombinant proteins market was valued at US$3.3 billion in 2024 and is projected to reach US$5.8 billion by 2030, expanding at a compound annual growth rate of 10.2%. Ma

Fetal Bovine Serum Market Gains Momentum as Stem Cell Research, Vaccine Innovation and Advanced Therapies Drive Demand for High-Quality, Ethically Sourced ProductsDublin, Sept. 30, 2026 (GLOBE NEWSWIRE) -- "Fetal Bovine Serum Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035" has been added to ResearchAndMarkets.com's offering. The global fetal bovine serum market was valued at USD 1.1 billion in 2025 and is projected to reach USD 2.3 billion by 2035, expanding

Demand is rising across solar, wearables, sensors and precision medicine, while nanostructuring and safer, durable materials enable smart coatings and light-powered devices.Dublin, Sept. 28, 2026 (GLOBE NEWSWIRE) -- "Photoactive Materials Market - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. Global Photoactive Materials Market to Reach US$1.2 Billion by 2030 as Energy, Healthcare and Sensing Applications Expand The global photoactive materials market was

Demand is rising in diagnostics, precision medicine and biopharma research, while nanotechnology, automation and AI unlock targeted therapies and high-throughput workflows.Dublin, Sept. 28, 2026 (GLOBE NEWSWIRE) -- "Magnetic Beads - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global magnetic beads market was valued at an estimated US$3.3 billion in 2025 and is projected to reach US$7.4 billion by 2032, advancing at a compound annual growth rate (CAG

Boost ROI via automated closed handling, resilient sourcing, tailored portfolios, quality-by-design, validated AI, compliance mapping and lifecycle stewardship.Dublin, Sept. 28, 2026 (GLOBE NEWSWIRE) -- "Grignard Reagents Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The Grignard Reagents Market research report provides a comprehensive assessment of industry growth, production trends, applications, technologies, and geographic opportunities. The market

Oxidative Stress Assay Market Gains Momentum as Chronic Disease Research, Personalized Medicine and Automated High-Throughput Kits Drive DemandDublin, Sept. 24, 2026 (GLOBE NEWSWIRE) -- "Oxidative Stress Assay Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035" has been added to ResearchAndMarkets.com's offering. Global Oxidative Stress Assay Market to Reach USD 2.7 Billion by 2035 as Biomarker Testing Expands The global oxidative stress assay market was valued a

Cell Culture Media Market Gains Momentum as Serum-Free Formulations, Biologics and Cell Therapies Drive DemandDublin, Sept. 24, 2026 (GLOBE NEWSWIRE) -- "Cell Culture Media Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035" has been added to ResearchAndMarkets.com's offering. Global Cell Culture Media Market to Reach USD 10.8 Billion by 2035, Driven by Biopharmaceutical Innovation The global cell culture media market was valued at USD 3.9 billion in 2025 and is

Merck KGaA (XTRA:MRK) has received shareholder approval from Bio-Techne investors for its planned acquisition of the US life sciences group. The vote clears a major corporate hurdle in the transaction process, with completion still subject to remaining regulatory reviews. The planned merger is expected to broaden the combined product set and customer reach across multiple stages of the life sciences workflow. The Bio-Techne shareholder approval is important, but it should not be the only...

Bio-Techne Corporation (NASDAQ: TECH) ("Bio-Techne"), a global provider of life science tools, reagents and diagnostic products, announced that Bio-Techne shareholders voted to approve and adopt the definitive agreement under which Merck KGaA, Darmstadt, Germany proposes to acquire Bio-Techne (the "Merger Agreement") at a Special Meeting of Shareholders held today.

Biologics, stricter purity rules and flexible manufacturing are driving demand for single-use, automated and continuous filtration, advanced membranes and sustainable systems.Dublin, Sept. 23, 2026 (GLOBE NEWSWIRE) -- "Pharmaceutical Filtration - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Pharmaceutical Filtration was estimated at US$8.0 Billion in 2025 and is projected to reach US$23.4 Billion by 2032, growing at a CAGR of 16.7% f

Demand is rising with pharmaceutical R&D, stricter drug-testing rules, advanced analytics and environmental monitoring, while trade shifts may reshape sourcing.Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- "Stable Isotope Labeled Compounds - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Stable Isotope Labeled Compounds was valued at US$343.5 Million in 2024 and is projected to reach US$432.5 Million by 2030, growing at a CAGR of 3.9% fro

Site-specific PEGylation is enabling safer, longer-acting biologics, while demand in chronic disease, targeted therapies and biosimilars creates opportunities for services and reagents.Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- "PEGylated Proteins - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for PEGylated Proteins was estimated at US$2.0 Billion in 2025 and is projected to reach US$4.1 Billion by 2032, growing at a CAGR of 10.6% from 2

Demand is rising for single-use, automated and real-time aseptic sampling as biopharma and food producers prioritize contamination control, continuous manufacturing and compliance.Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- "Aseptic Sampling - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Aseptic Sampling was estimated at US$867.4 Million in 2025 and is projected to reach US$1.3 Billion by 2032, growing at a CAGR of 6.3% from 2025 to 2

Oligonucleotide Synthesis Gains Momentum as Precision Medicine, Gene Editing and Therapeutic Pipelines Drive GMP Capacity Expansion and PartnershipsDublin, Sept. 15, 2026 (GLOBE NEWSWIRE) -- "Oligonucleotide Synthesis Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035" has been added to ResearchAndMarkets.com's offering. Global Oligonucleotide Synthesis Market to Reach USD 8.6 Billion by 2035, Driven by Precision Medicine and Therapeutic Innovation The global oli

The global single-use bioreactors market is forecast to grow from USD 5.43 billion in 2026 to USD 9.58 billion by 2031, at a 12.0% CAGR. Growth is driven by biologics, biosimilars, vaccine manufacturing, CDMO outsourcing, and flexible bioprocessing. Bioproduction and monoclonal antibodies led the market in 2025, while Asia Pacific is expected to grow fastest through 2031. Key players include Sartorius, Danaher, Thermo Fisher Scientific, and Merck KGaA.Dublin, Sept. 15, 2026 (GLOBE NEWSWIRE) -- "

TwoStep will begin a Phase I study of TS-104, with patient enrolment expected to commence later this year.

PostEra, a biotechnology company specializing in artificial intelligence for small molecule drug discovery and reproductive endocrinology, today announced that EMD Serono, Inc., the Healthcare business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, has acquired two of PostEra's programs directed at fertility indications.

500-Page Report Spans 450 Data Tables Across Product, Species, Host Cell, and Application Segments as Human Recombinant Proteins Lead Demand Research Use Recombinant Protein Market Research Use Recombinant Protein Market Dublin, Sept. 08, 2026 (GLOBE NEWSWIRE) -- The "Research Use Recombinant Protein Market by Product, Product Formulation, Species, Host Cell, Application, End User, Region - Global Forecast to 2031" has been added to ResearchAndMarkets.com's offering. Research Use Recombinant Pro

500-Page Report Ranks Suppliers by Competitive Position Across the Company Evaluation Matrix as Infectious Disease Testing Drives the Largest Application Segment IVD Raw Material Market IVD Raw Material Market Dublin, Sept. 08, 2026 (GLOBE NEWSWIRE) -- The "IVD Raw Material Market by Product Type, Technology, Application, Supply Source, Origin, End User - Global Forecast to 2031" has been added to ResearchAndMarkets.com's offering. The global in vitro diagnostics (IVD) raw material market is pro